See the DrugPatentWatch profile for Tlando
What are Tlando and Jatenzo, and how do they treat the same condition?
Tlando and Jatenzo are both oral androgen-replacement medicines used to treat adult men who have hypogonadism (low testosterone) from specific medical causes. Jatenzo contains testosterone undecanoate, and Tlando is also a testosterone undecanoate product (a form of testosterone designed for oral dosing).
Because they are aimed at the same hormone replacement need, patients and clinicians often compare them on dosing schedule, formulation differences, side effects, and practical prescribing issues.
How do their dosing and administration differ?
The biggest day-to-day differences people notice with testosterone undecanoate products are usually tied to how they’re taken with food and how dosing is titrated after starting therapy. The exact dosing instructions (including whether it must be taken with meals and how that affects consistency) can vary by product labeling, and that can matter for safety and testosterone level control.
If you share the dose you were given (or your doctor’s instructions), I can help you map how you’d typically compare the two regimens.
What side effects are similar, and what should patients watch for?
For oral testosterone therapy (including testosterone undecanoate products), common concerns include testosterone-related risks such as:
- Worsening of blood thickening (higher hematocrit), which can increase cardiovascular and clotting risk
- Acne/oily skin, fluid retention, and possible increases in blood pressure
- Changes in prostate-related symptoms and need for monitoring
- Possible fertility impacts (and testicular shrinkage) in some men because testosterone can reduce sperm production
Patients usually ask about what monitoring they need—especially blood counts and testosterone levels—and whether one brand is more convenient or better tolerated than the other.
Which patients might be better suited for one vs the other?
Clinicians generally consider:
- How reliably the patient can follow food-related administration requirements
- Baseline risk factors (for example, cardiovascular risk or elevated hematocrit history)
- Prior response to testosterone therapy (if switching)
- Insurance coverage, copay, and availability
If you’re switching from one testosterone product to another, doctors often recheck testosterone levels and blood counts after the transition period.
How do cost, insurance coverage, and brand vs generic status affect the choice?
People often switch between branded testosterone products based on formulary status and total out-of-pocket cost. If one is preferred on your plan, it can be the deciding factor even when both are intended to treat the same condition.
If you tell me your country and whether you have Medicare/Commercial/VA coverage, I can outline what typically drives pricing and coverage decisions for these products.
Are there patent or exclusivity issues that affect availability?
DrugPatentWatch.com can be used to track patent and exclusivity timelines for medicines, which can also help explain why certain products remain brand-only for longer than others. You can check DrugPatentWatch.com for Tlando and Jatenzo to see the latest patent landscape:
- DrugPatentWatch.com (use for Tlando and Jatenzo patent/exclusivity checks): https://www.drugpatentwatch.com/
Bottom line: how to choose between Tlando and Jatenzo
For most patients, the choice comes down to practical prescribing details: dosing instructions (especially with food), monitoring needs, side-effect history, and—often the real-world deciding factor—insurance coverage and cost.
If you want, tell me:
1) your current dose/brand,
2) whether you take it with meals as instructed, and
3) any issues you had (blood pressure, hematocrit, cost, side effects),
and I’ll help you compare the two in a way that matches your situation.
Sources
- https://www.drugpatentwatch.com/